product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
α-Synuclein Antibody (IF Preferred)
catalog :
2628
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - frozen section, immunohistochemistry - free floating section
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - free floating section; mouse; 1:100; fig 5
Smith B, Santos M, Marshall M, Cantuti Castelvetri L, Lopez Rosas A, Li G, et al. Neuronal inclusions of ?-synuclein contribute to the pathogenesis of Krabbe disease. J Pathol. 2014;232:509-21 pubmed publisher
  • western blot; human
Guardia Laguarta C, Area Gomez E, Rüb C, Liu Y, Magrane J, Becker D, et al. ?-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci. 2014;34:249-59 pubmed publisher
Sekigawa A, Fujita M, Sekiyama K, Takamatsu Y, Hatano T, Rockenstein E, et al. Distinct mechanisms of axonal globule formation in mice expressing human wild type ?-synuclein or dementia with Lewy bodies-linked P123H ?-synuclein. Mol Brain. 2012;5:34 pubmed publisher
product information
SKU :
2628S
Product-Name :
α-Synuclein Antibody (IF Preferred)
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Immunofluorescence (Frozen)
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
18
Host :
Rabbit
Target :
Synuclein-alpha
Primary-Protein :
SNCA
Alt-Names :
Alpha-synuclein,MGC110988,NACP,Non-A beta component of AD amyloid,Non-A4 component of amyloid precursor,PARK1,PARK4,PD1,SNCA,SYUA,alpha-synuclein, isoform NACP140,non A-beta component of AD amyloid,non-A4 component of amyloid,synuclein, alpha (non A4 component of amyloid precursor)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.